India, May 27 -- 20/20 Biolabs, Inc. (AIDX), which develops AI-powered laboratory-based blood tests for the early detection and prevention of cancers and chronic diseases, announced that its OneTest multi-cancer early detection blood test has been selected by the state of Vermont for a statewide firefighter cancer screening initiative in partnership with National Diagnostic Services (NDS).
OneTest is 20/20 Biolabs' multi-cancer early detection blood test designed to help detect cancer early by combining cancer-associated biomarkers, clinical factors, and artificial intelligence.
Notably, the contract is expected to generate approximately $0.5 million in revenue for the firm to test approximately one-third of eligible Vermont firefighters ...